Advertisement

Topics

Amgen-Aktie: Vertrauen in Migräne-Medikament! - Aktienanalyse

11:04 EDT 29 Jun 2017 | FinanzNachrichten

New York - Amgen-Aktienanalyse der Analystin Leah Rush Cann von Oppenheimer: Die Aktienanalystin Leah Rush Cann vom Investmenthaus Oppenheimer äußert laut einer Aktienanalyse in Bezug auf die Aktie...

Original Article: Amgen-Aktie: Vertrauen in Migräne-Medikament! - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "Amgen-Aktie: Vertrauen in Migräne-Medikament! - Aktienanalyse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...